1. pl
  2. en

Multisystem inflammatory syndrome associated with COVID-19

Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS)

Multisystem inflammatory syndrome in children (MIS-C)

Pediatric infalmmatory multisystem syndrome (PIMS) is a rare complication of SARS-CoV-2 infection in children. PIMS resembles infection - children with PIMS present with fever, they frequently have abdominal pain, diarrhea, rash, conjunctivitis. However, the disease is not infectious, and treatment involves medications which supress hyperinflammation in the body.

In some children the disease course is very severe and it might be life-threatening. Thus, children with PIMS should be treated in a hospital.

PIMS is a rare complication of COVID-19. However, the more prevalent COVID-19, the more PIMS cases follow. PIMS waves emerge approximately 3-6 weeks after COVID-19 waves in the society.

MOIS-CoR (MultiOrgan Inflammatory Syndromes COVID Related) is a scientific project, which includes national registry of inflammatory syndromes in children, launched on May 2020. The data from registry reveal PIMS prevalence in our country, as well as its characteristics. MOIS-CoR is a Polish doctors' voluntary initiative.

What is MOIS-CoR?

What is PIMS?

Approach to a child with Multisystem Inflammatory Syndrome associated with COVID-19. Recommendations by the Polish Paediatric Society Expert Group